Rachel Klemovitch, Assistant Editor02.22.24
3M has filed a Form 10 registration statement with the U.S. Securities and Exchange Commission for the planned spin-off of its Health Care business Solventum.
With final approval from 3M’s board of directors, Solventm is planned to separate from the company on April 1, 2024. Solventum has also applied to be listed on the New York Stock Exchange as “SOLV.”
On March 19, 2024, Solventum will host an Investor Day in New York City. Bryan Hanson, CEO and Wayde McMillan, chief financial officer as well as fellow leadership will present a business overview and plans for Solventum’s spin from 3M.
Registration information will be provided in the coming weeks. A live broadcast as well as an archive video will be available during and after the live event.
With final approval from 3M’s board of directors, Solventm is planned to separate from the company on April 1, 2024. Solventum has also applied to be listed on the New York Stock Exchange as “SOLV.”
On March 19, 2024, Solventum will host an Investor Day in New York City. Bryan Hanson, CEO and Wayde McMillan, chief financial officer as well as fellow leadership will present a business overview and plans for Solventum’s spin from 3M.
Registration information will be provided in the coming weeks. A live broadcast as well as an archive video will be available during and after the live event.